Le Lézard
Classified in: Health
Subject: PER

Wanda Diak Announces Retirement from Cancer Hope Network


CHESTER, N.J., Nov. 15, 2018 /PRNewswire-PRWeb/ -- After 22 years at the helm, Cancer Hope Network Executive Director Wanda Diak will retire December 2018. Under her guidance, the organization has transformed from a loosely-organized group of dedicated New Jersey volunteers to a patient-focused team of more than 400 volunteers and staff that serves clients in the US and Canada. Cancer Hope Network Support Volunteers have faced more than 80 types of cancer and speak 15 languages.

Following her own bout with ovarian cancer, she joined the Cancer Hope Network (Then known as CHEMOcare) in 1997 as part of a Loaned Executive program through AT&T. What was supposed to be a two year volunteer project soon became a second career.

"Cancer Hope Network has been an opportunity to fulfill a promise I made to myself during a particularly dark time of treatment," Diak recalls. "I swore that if I had a good outcome to my treatment, I would help others who are facing a similar diagnosis. As a Support Volunteer, I've been able to help nearly 300 clients. As Executive Director, I've been able to lead the team that's facilitated more than 33,000 matches between cancer survivors, patients and caregivers."

"Wanda has served with distinction and compassion," said Board President Adam Weissenberg. "For more than two decades, her leadership has helped Cancer Hope Network grow by leaps and bounds, building partnerships across the nation and developing innovative programs like TACT (Talking About Clinical Trials). She leaves big shoes to fill, but has positioned CHN to continue creating hope and connection for cancer patients and their loved ones."

For more information, or to schedule an interview with Diak, please contact Sarah Miretti Cassidy, Director of Marketing. scassidy(at)cancerhopenetwork.org | 908.879.4039 ex 20

To learn more about Wanda's impact visit http://www.cancerhopenetwork.org/Wanda

About Cancer Hope Network
Cancer Hope Network provides free one-on-one emotional support to adult cancer patients and their loved ones. Each of CHN's 400+ volunteers is at least one year post-treatment or successfully undergoing maintenance therapies. They have faced more than 80 cancer types and speak 15 languages. Our volunteers offer support from diagnosis, through treatment and into recovery. Cancer Hope Network serves cancer patients in the United States and Canada.

 

SOURCE Cancer Hope Network


These press releases may also interest you

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...



News published on and distributed by: